| 000 | 01828cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223031007.0 | ||
| 008 | 140609s2013 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.33.Ph.D.2013.Mo.E | ||
| 100 | 0 | _aMohamed Hassany Barbary | |
| 245 | 1 | 0 |
_aEffect of vitamin D supplementation on end treatment response to peginterferon alfa - 2b / ribavirin combination in chronic hepatitis C genotype 4 / _cMohamed Hassany Barbary ; Supervised Gamal Eldin Esmat Mohamed , Maissa Elsaid Elraziky , Wahid Halim Doss |
| 246 | 1 | 5 | _aتأثير اضافة فيتامين د على النتيجة النهائية لعلاج فيروس "سى" السلالة الرابعة باستخدام عقارى الأنترفيرون و الريبافيرن |
| 260 |
_aCairo : _bMohamed Hassany Barbary , _c2013 |
||
| 300 |
_a172 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine | ||
| 520 | _aHCV infection is the main cause of chronic liver diseases. The current standard treatment for chronic HCV is not satisfactory especially with the moderate response rates and currently known side effects for the treatment. Many coming reports showed the possible role of vitamin D supplementation in sugmenting the response to SOC therapy of HCV | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aHCV | |
| 653 | 4 | _aPegylated interferon | |
| 653 | 4 | _aVitamin D | |
| 700 | 0 |
_aGamal Eldin Esmat Mohamed , _eSupervisor |
|
| 700 | 0 |
_aMaissa Elsaid Elraziky , _eSupervisor |
|
| 700 | 0 |
_aWahid Halim Doss , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c46220 _d46220 |
||